Recombinant multi-species NBAS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NBAS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein with two leucine zipper domains, a ribosomal protein S14 signature domain and a Sec39 like domain. The protein is thought to be involved in Golgi-to-ER transport. Mutations in this gene are associated with short stature, optic nerve atrophy, and Pelger-Huet anomaly. [provided by RefSeq, Oct 2012]
The Alternative Names of target: 4933425L03Rik,ILFS2,NAG,NBAS,NBAS subunit of NRZ tethering complex,Nag,Nbas,Neuroblastoma-amplified gene protein,Neuroblastoma-amplified sequence,SOPH

Target products collectionGo to NBAS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1239-Ag-1/ GM-Tg-hg-IP1239-Ag-2 Human NBAS protein Human
GM-Tg-rg-IP1239-Ag-1/ GM-Tg-rg-IP1239-Ag-2 Rat NBAS protein Rat
GM-Tg-mg-IP1239-Ag-1/ GM-Tg-mg-IP1239-Ag-2 Mouse NBAS protein Mouse
GM-Tg-cynog-IP1239-Ag-1/ GM-Tg-cynog-IP1239-Ag-2 Cynomolgus/Rhesus macaque NBAS protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1239-Ag-1/ GM-Tg-felg-IP1239-Ag-2 Feline NBAS protein Feline
GM-Tg-cang-IP1239-Ag-1/ GM-Tg-cang-IP1239-Ag-2 Canine NBAS protein Canine
GM-Tg-bovg-IP1239-Ag-1/ GM-Tg-bovg-IP1239-Ag-2 Bovine NBAS protein Bovine
GM-Tg-equg-IP1239-Ag-1/ GM-Tg-equg-IP1239-Ag-2 Equine NBAS protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1239-Ag-1/ GM-Tg-hg-IP1239-Ag-2; GM-Tg-rg-IP1239-Ag-1/ GM-Tg-rg-IP1239-Ag-2;
GM-Tg-mg-IP1239-Ag-1/ GM-Tg-mg-IP1239-Ag-2; GM-Tg-cynog-IP1239-Ag-1/ GM-Tg-cynog-IP1239-Ag-2;
GM-Tg-felg-IP1239-Ag-1/ GM-Tg-felg-IP1239-Ag-2; GM-Tg-cang-IP1239-Ag-1/ GM-Tg-cang-IP1239-Ag-2;
GM-Tg-bovg-IP1239-Ag-1/ GM-Tg-bovg-IP1239-Ag-2; GM-Tg-equg-IP1239-Ag-1/ GM-Tg-equg-IP1239-Ag-2
Products Name NBAS protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NBAS
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NBAS protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.